inVentiv Health, Inc. (NASDAQ: VTIV) today announced it has acquired ParagonRx, a leading consulting company specializing in pharmaceutical risk management ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE